Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FORGOTTEN HISTORY: 20 | History Defined

‘Groundbreaking’ drug could slow progression of type 1 diabetes

A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS.

Evening Standard

Persistent and widespread medicine shortages putting patients at risk

The ‘severe, persistent, and disruptive’ shortages often impact patients with ADHD, menopause and diabetes, a new report says

The Independent UK

Medicine shortages put patients at risk, MPs and peers warn

The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Ageing isn’t the same everywhere – why inflammation may be a lifestyle problem

For years, scientists have believed that inflammation inevitably increases with age, quietly fuelling diseases like heart disease, dementia and diabetes. But a new study of Indigenous populations challenges that idea and could reshape how we think about ageing itself.

The Conversation

Vital steps to move the NHS from cure to prevention

Letters: Readers respond to Guardian coverage of health inequalities in Britain and the government’s 10-year plan for the health service

The Guardian - UK

Your holiday cookout could be killing you

New study builds on years of research tying processed foods to higher risks of obesity, heart disease, diabetes, and cancer.

The Independent UK

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes.

LiveScience

Read news from The Economist, FT, and more,
with one subscription

Eating lots of red meat, other inflammatory foods during pregnancy raises risk of childhood diabetes

The study indicates that women’s diets may have long-lasting effects on their children’s health.

Euronews

The rising rate of type 2 diabetes in young New Zealanders is becoming a health crisis

No longer just a condition of middle age, type 2 diabetes is increasingly affecting children, teenagers and young adults in New Zealand. And our health system is nowhere near ready to manage this surge.

The Conversation

Triple threat of smoking, drinking and weight ‘puts a million in England at risk of early death’

Exclusive: Three risky behaviours can mean people dying 20 years earlier than they should, says senior doctor

The Guardian - UK

Hundreds of weight loss and diabetes jab users report pancreas problems

UK health officials launch study into side-effects of weight loss drugs after increased reports of acute pancreatitis

The Guardian - UK

People with severe diabetes cured in small stem cell trial

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.

The Conversation

‘Holy grail’ diet pill burns fat without affecting appetite or muscle mass unlike weight loss jabs

This new pill works by triggering the metabolism in the muscles, activating them to burn more fat, without the gastrointestinal side effects of weight loss jabs

The Independent UK

Mounjaro on the NHS: Expert advice on what you need to know

Mounjaro has been approved for both type 2 diabetes and weight loss, but access will be limited by strict eligibility criteria

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

The Independent UK

Mounjaro is available on the NHS. Here’s what to do if you’re not eligible

Mounjaro has been approved for both type 2 diabetes and weight loss; however, access will be limited by strict eligibility criteria

The Independent UK

New once-a-month drug could treat diabetes and obesity, scientists say

Researchers say experimental drug’s less frequent dosing could improve adherence and offer long-term control

The Conversation

How pregnant women are tested for gestational diabetes is changing. Here’s what this means for you

How Australian pregnant women are tested for gestational diabetes is set to change, with new national guidelines released today.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

I was diagnosed with PCOS – and was soon drowning in misinformation

From medically unqualified influencers pushing expensive supplements online, to nurses peddling myths about pregnancy, I had to find out all I could about my condition myself. This is what I’ve learned

AAP

'Game changer' diabetes pill a step closer after trials

A new type of diabetes pill has been shown to act in a similar way to injectable treatments like Ozempic, with more like it in the pipeline.

The Guardian - US

Key RFK Jr advisers stand to profit from a new federal health initiative

The Maha campaign seeks to warn Americans of the dangers of ultra-processed foods

The Independent UK

Losing weight in your 40s and 50s may seem unbearably hard — but it could keep you alive longer

Benefits included a reduced risk for cardiovascular disease and diabetes

Bored Panda

Grandpa Makes Family Apologize To Woman By Threatening To Withdraw Wedding Money

How would you feel if you had diabetes and your own sister pressured you this way?

International Business Times UK

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act immediately to protect their health.

The Independent UK

GPs to contact patients with key warning signs of pancreatic cancer

GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss.

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Exeter

the US Food and Drug Administration

70 stories

Insulet

52 stories

Karolinska Institutet

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.